CVS Health Number of Shares Shorted |
The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
| Symbol | Refresh |
Number of Shares Shorted Analysis
Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.CVS Health |
| = | 46.96 M |
Distress Driver Correlations
| Click cells to compare fundamentals | View All Correlations |
Number of Shares Shorted Pattern
The weighted average number of shares or units issued and outstanding that are used by the company to calculate Earnings per Basic Share; determined based on the timing of issuance of shares or units in the period.About Number of Shares Shorted
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect price of the stock.Compare to competitionIncome
CVS Health Income Change Over Time
Accumulated Other Comprehensive Income
Based on recorded statements CVS Health Corporation has 46.96 M of outstending shares currently sold short by investors. This is 1188.9% higher than that of the Healthcare sector, and significantly higher than that of Healthcare Services industry, The Number of Shares Shorted for all stocks is 1349.47% lower than the firm.
Peer Comparison
CVS Health Number of Shares Shorted Comparison
Fundamental Indicators
Current CVS Health financial ratios
| Return On Equity | 18.39 % | ||
| Return On Asset | 5.55 % | ||
| Profit Margin | 3.59 % | ||
| Operating Margin | 6.79 % | ||
| Current Valuation | 92.26 B | ||
| Shares Outstanding | 1.02 B | ||
| Shares Owned by Insiders | 0.26 % | ||
| Shares Owned by Institutions | 85.96 % | ||
| Number of Shares Shorted | 46.96 M | ||
| Price to Earning | 11.30 times | ||
| Price to Book | 1.94 times | ||
| Price to Sales | 0.40 times | ||
| Revenue | 185.94 B | ||
| Gross Profit | 28.55 B | ||
| EBITDA | 12.62 B | ||
| Net Income | 6.65 B | ||
| Cash and Equivalents | 42.14 B | ||
| Cash per Share | 41.45 times | ||
| Total Debt | 65.09 B | ||
| Debt to Equity | 168.30 % | ||
| Current Ratio | 2.37 times | ||
| Book Value Per Share | 38.06 times | ||
| Cash Flow from Operations | 5.05 B | ||
| Short Ratio | 5.18 times | ||
| Earnings Per Share | 6.52 times | ||
| Price to Earnings To Growth | 1.11 times | ||
| Number of Employees | 160 K | ||
| Beta | 0.88 | ||
| Market Capitalization | 74.9 B | ||
| Total Asset | 93.66 B | ||
| Retained Earnings | 38.98 B | ||
| Working Capital | 7.21 B | ||
| Current Asset | 30.38 B | ||
| Current Liabilities | 23.17 B | ||
| Z Score | 1.6 | ||
| Five Year Return | 1.82 % | ||
| Last Dividend Paid | 2.0 |